Transcriptomics,Genomics

Dataset Information

50

Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver [Chimeric Liver Experiments]


ABSTRACT: High doses of sodium phenobarbital (NaPB), a constitutive androstane receptor (CAR) activator, have been shown to produce hepatocellular tumors in rodents by a mitogenic mode of action (MOA) involving CAR activation. The effect of 1 week dietary treatment with NaPB on liver weight and histopathology, hepatic CYP2B enzyme activity and CYP2B/3A mRNA expression, replicative DNA synthesis and selected genes related to cell proliferation and functional transcriptomic and metabolomic analyses was studied in male CD-1 mice, Wistar Hannover (WH) rats and chimeric mice with human hepatocytes. The treatment of chimeric mice with 1000-1500 ppm NaPB resulted in plasma levels around 3-5 fold higher than those observed in human subjects given therapeutic doses of NaPB. NaPB produced dose-dependent increases in hepatic CYP2B activity and CYP2B/3A mRNA levels in all animal models. Integrated functional metabolomic and transcriptomic analyses demonstrated the responses to NaPB in human liver were clearly different from those in rodents. While NaPB produced a dose-dependent increase in hepatocyte replicative DNA synthesis in CD-1 mice and WH rats, no increase in replicative DNA synthesis was observed in human hepatocyte-originated areas of chimeric mice. In addition, treatment with NaPB had no effect on Ki-67, PCNA, GADD45β, and MDM2 mRNA expression in chimeric mice, whereas significant increases were observed in CD-1 mice and/or WH rats. Thus, while NaPB could activate CAR in rodent and human hepatocytes, NaPB did not increase replicative DNA synthesis in human hepatocytes of chimeric mice, whereas it was mitogenic to rat and mouse hepatocytes. As human hepatocytes are refractory to the mitogenic effects of NaPB, the MOA for NaPB-induced rodent liver tumor formation is thus not relevant for humans. Overall design: Male chimeric mice (4-5 animals/dose) also fed diets containing 0 (control) or 1000 ppm NaPB for 7 days. Liver samples were used for gene expression analysis.

INSTRUMENT(S): Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Feature Number version)

SUBMITTER: Kayo Sumida  

PROVIDER: GSE57056 | GEO | 2014-08-29

SECONDARY ACCESSION(S): PRJNA245333

REPOSITORIES: GEO

altmetric image

Publications

Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.

Yamada Tomoya T   Okuda Yu Y   Kushida Masahiko M   Sumida Kayo K   Takeuchi Hayato H   Nagahori Hirohisa H   Fukuda Takako T   Lake Brian G BG   Cohen Samuel M SM   Kawamura Satoshi S  

Toxicological sciences : an official journal of the Society of Toxicology 20140821 1


High doses of sodium phenobarbital (NaPB), a constitutive androstane receptor (CAR) activator, have been shown to produce hepatocellular tumors in rodents by a mitogenic mode of action (MOA) involving CAR activation. The effect of 1-week dietary treatment with NaPB on liver weight and histopathology, hepatic CYP2B enzyme activity and CYP2B/3A mRNA expression, replicative DNA synthesis and selected genes related to cell proliferation, and functional transcriptomic and metabolomic analyses was stu  ...[more]

Similar Datasets

2014-08-29 | E-GEOD-57055 | ArrayExpress
2014-08-29 | E-GEOD-57057 | ArrayExpress
1000-01-01 | S-EPMC6062351 | BioStudies
1000-01-01 | S-EPMC5684092 | BioStudies
2018-01-01 | S-EPMC6038120 | BioStudies
2014-01-01 | S-EPMC4089507 | BioStudies
1000-01-01 | S-EPMC6062386 | BioStudies
2020-01-01 | S-EPMC7196313 | BioStudies
2010-01-01 | S-EPMC2907178 | BioStudies
2017-01-01 | S-EPMC5261028 | BioStudies